reference/8841715

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8841715

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Review
endingPage	728
issn	1881-1469 0021-8820
issueIdentifier	10
pageRange	719-728
publicationName	The Journal of Antibiotics
startingPage	719
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e5b21b0e17980757c6b6505e1fad058d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0d6786c14e35ab0c92ab634e52de5d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ca0b45962a5a62ef43f07123284f7022
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_07a042575cee02af06e02e432b9b3809 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4d1d0e90029bef731d9fc3d968876000
bibliographicCitation	Grzelak EM, Choules MP, Gao W, Cai G, Wan B, Wang Y, McAlpine JB, Cheng J, Jin Y, Lee H, Suh J, Pauli GF, Franzblau SG, Jaki BU, Cho S. Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening. The Journal of Antibiotics. 2019 Jul 11;72(10):719–28. doi: 10.1038/s41429-019-0205-9.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f435e9ed28e7c4d71db257b4bd71eb8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1bd1a02807fb785f52b986f580dd2ac6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1634d6266453a2cf242efbfa1b15a45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d3fe725853cdf5afd19410bda4f2e2c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7b7d38e427aeb39b0b74642d3804950 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1022-4326 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04b935a4364e6a035685ad2a27a6b258 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1771-3245 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb530bad5ad88764ee0c10914aa739ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8698-0243 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec2f4ad9efb52b33ad90190c74e7fa87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9055f23ee8b7319dfbd09a3f415c0f7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9c6b810649216ba278bfedaef9814b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91d3920316958fa148dc1d84af6bbf1c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74b94d11be0109b26932e6093175c49e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0843-1449
date	2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC6760628 https://pubmed.ncbi.nlm.nih.gov/31292530 https://doi.org/10.1038/s41429-019-0205-9
isPartOf	https://portal.issn.org/resource/ISSN/0021-8820 https://portal.issn.org/resource/ISSN/1881-1469 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4490
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening
discusses	http://id.nlm.nih.gov/mesh/M0001515
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11367 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9505

Total number of triples: 46.